Stocks and Investing Stocks and Investing
Tue, February 23, 2021
Mon, February 22, 2021

Etzer Darout Downgraded (ALNY) to Hold and Held Target at $162 on, Feb 22nd, 2021


Published on 2024-10-27 15:43:40 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of Guggenheim, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold and Held Target at $162 on, Feb 22nd, 2021.

Etzer has made no other calls on ALNY in the last 4 months.



There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 3 agree with Etzer's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joel Beatty of "Citigroup" Downgraded from Strong Buy to Hold and Increased Target to $175 on, Friday, February 12th, 2021
  • Do Kim of "BMO Capital" Downgraded from Buy to Hold and Held Target at $185 on, Monday, January 25th, 2021
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $93 on, Wednesday, November 25th, 2020


These are the ratings of the 4 analyists that currently disagree with Etzer


  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $196 on, Friday, February 12th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $180 on, Friday, February 12th, 2021
  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $206 on, Friday, February 12th, 2021
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $235 on, Friday, February 12th, 2021
Contributing Sources